Sciclone Pharmaceuticals Stock Profit Margin
SciClone Pharmaceuticals fundamentals help investors to digest information that contributes to SciClone Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of SciClone Stock. The fundamental analysis module provides a way to measure SciClone Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SciClone Pharmaceuticals stock.
SciClone |
SciClone Pharmaceuticals Company Profit Margin Analysis
SciClone Pharmaceuticals' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current SciClone Pharmaceuticals Profit Margin | 0.21 % |
Most of SciClone Pharmaceuticals' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SciClone Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, SciClone Pharmaceuticals has a Profit Margin of 0.21%. This is 101.87% lower than that of the sector and 98.43% lower than that of the Profit Margin industry. The profit margin for all United States stocks is 116.54% lower than that of the firm.
SciClone Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SciClone Pharmaceuticals' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SciClone Pharmaceuticals could also be used in its relative valuation, which is a method of valuing SciClone Pharmaceuticals by comparing valuation metrics of similar companies.SciClone Pharmaceuticals is currently under evaluation in profit margin category among related companies.
SciClone Fundamentals
| Return On Equity | 0.19 | |||
| Return On Asset | 0.16 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 25.82 % | |||
| Current Valuation | 422 M | |||
| Shares Outstanding | 52.19 M | |||
| Shares Owned By Insiders | 10.03 % | |||
| Shares Owned By Institutions | 79.96 % | |||
| Number Of Shares Shorted | 1.21 M | |||
| Price To Earning | 13.75 X | |||
| Price To Book | 2.33 X | |||
| Price To Sales | 3.38 X | |||
| Revenue | 172.02 M | |||
| Gross Profit | 137.2 M | |||
| EBITDA | 45.42 M | |||
| Net Income | 43.31 M | |||
| Cash And Equivalents | 157.33 M | |||
| Cash Per Share | 3.01 X | |||
| Total Debt | 2.73 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 8.36 X | |||
| Book Value Per Share | 3.53 X | |||
| Cash Flow From Operations | 35.74 M | |||
| Short Ratio | 2.34 X | |||
| Earnings Per Share | 0.81 X | |||
| Price To Earnings To Growth | 0.84 X | |||
| Number Of Employees | 590 | |||
| Beta | 1.25 | |||
| Market Capitalization | 581.94 M | |||
| Total Asset | 216.62 M | |||
| Retained Earnings | (115.06 M) | |||
| Working Capital | 131.7 M | |||
| Current Asset | 168.52 M | |||
| Current Liabilities | 36.82 M |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in SciClone Stock
If you are still planning to invest in SciClone Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SciClone Pharmaceuticals' history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |